Breast Cancer Trial, Recruiting NCT06721065 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06721065
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Patients (Phase 1):

  • Adults aged 18 or older
  • People whose preferred language for healthcare is Spanish or Mandarin
  • People who cannot speak English "very well"
  • People who have been diagnosed with breast cancer or gastrointestinal cancer
  • People who are attending their first or second appointment with an oncology team at MSK
  • People who agree to have their appointments audio-recorded

Healthcare Providers (Phase 1):

  • Breast or gastrointestinal cancer doctors, advanced practice providers, or nurses who see patients
  • Providers who do not speak Spanish and/or Mandarin (providers who speak one but not the other may still be eligible)
  • Providers who agree to be audio-recorded

Clinic Staff (Phase 2):

  • Staff members who work or worked at one of the study clinic sites during the Phase 1 study period
  • Staff members who agree to be audio-recorded

Who may not be able to join:

Patients (Phase 1):

  • People experiencing significant psychiatric symptoms that would make it difficult to complete assessments, interviews, or the consent process
  • People with a cognitive condition such as delirium or dementia that would make it difficult to give meaningful consent or take part in data collection

Healthcare Providers (Phase 1) and Clinic Staff (Phase 2):

  • No exclusion criteria have been listed for these groups

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francesca Gany, MD, MS, Memorial Sloan Kettering Cancer Center

Phone: 646-888-8054

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 December 2024
Est. completion
2 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of interpretation errors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov